Evidence map›Paper›PMID 27569543›Full record

ArticleBiological psychiatry2017

Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles.

Rosemary C Bagot, Hannah M Cates, Immanuel Purushothaman, Vincent Vialou, Elizabeth A Heller, Lynn Yieh, Benoit LaBonté, Catherine J Peña, Li Shen, Gayle M Wittenberg and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 1 synthesis or guideline pooled it, 192 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Contribution of the Serotonin 5-HTNeuropsychopharmacology reports · 2026
    Article
  4. Article
  5. Transcriptional profiles of antidepressant resistance across the corticolimbic pathway of chronically stressed mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The hippocampus as a central hub in ketamine's antidepressant action: from molecules to circuit rewiring.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Rosemary C BagotFishberg Department of Neuroscience and Friedman Brain Institute , Icahn School of Medicine at Mount Sinai, New York, New York.
Hannah M CatesFishberg Department of Neuroscience and Friedman Brain Institute , Icahn School of Medicine at Mount Sinai, New York, New York.
Immanuel PurushothamanFishberg Department of Neuroscience and Friedman Brain Institute , Icahn School of Medicine at Mount Sinai, New York, New York.
Vincent VialouFishberg Department of Neuroscience and Friedman Brain Institute , Icahn School of Medicine at Mount Sinai, New York, New York.
Elizabeth A HellerFishberg Department of Neuroscience and Friedman Brain Institute , Icahn School of Medicine at Mount Sinai, New York, New York.
Lynn YiehJanssen Research & Development, LLC, Titusville, New Jersey.
Benoit LaBontéFishberg Department of Neuroscience and Friedman Brain Institute , Icahn School of Medicine at Mount Sinai, New York, New York.
Catherine J PeñaFishberg Department of Neuroscience and Friedman Brain Institute , Icahn School of Medicine at Mount Sinai, New York, New York.
Li ShenFishberg Department of Neuroscience and Friedman Brain Institute , Icahn School of Medicine at Mount Sinai, New York, New York.
Gayle M WittenbergJanssen Research & Development, LLC, La Jolla, California.
Eric J NestlerFishberg Department of Neuroscience and Friedman Brain Institute , Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: eric.nestler@mssm.edu.
Icahn School of Medicine at Mount Sinai · USAllen Institute for Brain Science · USJanssen (United States) · US

Funding

REPRESSIVE HISTONE AND DNA METHYLATION IN RODENT DEPRESSION MODELSP50MH096890 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TAMMINGA, CAROL A · 2012 to 2021
$20.2M
Using neuroeconomics to disentangle the transcriptional mechanisms underlying resilience versus susceptibility to stressR01MH051399 · NIMH · YALE UNIVERSITY · PI NESTLER, ERIC J. · 1994 to 2023
$10.2M
Glial-mediated synaptic remodeling in drug addictionR01DA040620 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Yan Dong, ERIC J. NESTLER · 2016 to 2026
$5.3M
Cocaine-induced Adaptation in NMDA Receptors in Nucleus AccumbensR01DA023206 · NIDA · WASHINGTON STATE UNIVERSITY · PI DONG, YAN · 2008 to 2017
$3.0M
NIDA NIH HHS R01 DA023206NIDA NIH HHS R01 DA040620NIMH NIH HHS P50 MH096890NIMH NIH HHS R01 MH051399
6 · The paper itself

Abstract

backgroundExamining transcriptional regulation by antidepressants in key neural circuits implicated in depression and understanding the relation to transcriptional mechanisms of susceptibility and natural resilience may help in the search for new therapeutic agents. Given the heterogeneity of treatment response in human populations, examining both treatment response and nonresponse is critical.

methodsWe compared the effects of a conventional monoamine-based tricyclic antidepressant, imipramine, and a rapidly acting, non-monoamine-based antidepressant, ketamine, in mice subjected to chronic social defeat stress, a validated depression model, and used RNA sequencing to analyze transcriptional profiles associated with susceptibility, resilience, and antidepressant response and nonresponse in the prefrontal cortex (PFC), nucleus accumbens, hippocampus, and amygdala.

resultsWe identified similar numbers of responders and nonresponders after ketamine or imipramine treatment. Ketamine induced more expression changes in the hippocampus; imipramine induced more expression changes in the nucleus accumbens and amygdala. Transcriptional profiles in treatment responders were most similar in the PFC. Nonresponse reflected both the lack of response-associated gene expression changes and unique gene regulation. In responders, both drugs reversed susceptibility-associated transcriptional changes and induced resilience-associated transcription in the PFC.

conclusionsWe generated a uniquely large resource of gene expression data in four interconnected limbic brain regions implicated in depression and its treatment with imipramine or ketamine. Our analyses highlight the PFC as a key site of common transcriptional regulation by antidepressant drugs and in both reversing susceptibility- and inducing resilience-associated molecular adaptations. In addition, we found region-specific effects of each drug, suggesting both common and unique effects of imipramine versus ketamine.

Indexed as

Resilience, PsychologicalTranscriptomeAmygdalaAnimalsBrainDepressive DisorderHippocampusImipramineKetamineMiceMice, Inbred C57BLNucleus AccumbensPrefrontal CortexSequence Analysis, RNAImipramineKetamineDepressionImipramineKetamineResilienceRNA-seqSusceptibility

Identifiers

PMID27569543
PMCPMC5164982
OpenAlexW2430804118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.